O'Donovan M R
Boots Pharmaceuticals Research Department, Nottingham, UK.
Mutagenesis. 1990 May;5(3):267-74. doi: 10.1093/mutage/5.3.267.
Salmonella typhimurium TA97a was added to the set of indicator strains routinely used for the Ames test in this laboratory (TA1535, TA1537, TA1538, TA98 and TA100) for a trial period during which a total of approximately 40 reference mutagens and novel pharmaceutical compounds were examined. The conclusions from this trial were as follows: (i) there are agents mutagenic for TA1537 which are not detected by TA97a. (ii) except for agents requiring the R factor plasmid, TA97a shows no increased sensitivity to mutagens when compared with TA1537 and (iii) nearly all the limited published database is for the original isolate, TA97, rather than TA97a, and the results obtained here indicate significant differences in response between the two; TA97a remains, therefore, essentially unvalidated.
鼠伤寒沙门氏菌TA97a被添加到本实验室常规用于艾姆斯试验的指示菌株组(TA1535、TA1537、TA1538、TA98和TA100)中,进行为期一段时间的试验,在此期间共检测了约40种参考诱变剂和新型药物化合物。该试验得出的结论如下:(i)存在对TA1537具有诱变性但未被TA97a检测到的试剂。(ii)除了需要R因子质粒的试剂外,与TA1537相比,TA97a对诱变剂没有表现出更高的敏感性;(iii)几乎所有有限的已发表数据库都是关于原始菌株TA97,而不是TA97a,此处获得的结果表明两者之间的反应存在显著差异;因此,TA97a基本上仍未经验证。